PUS Stock Overview
Engages in the development, manufacture, and distribution of monitoring, diagnosis, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
PULSION Medical Systems SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €16.30 |
| 52 Week High | €17.50 |
| 52 Week Low | €12.00 |
| Beta | 0.021 |
| 11 Month Change | 5.84% |
| 3 Month Change | -0.61% |
| 1 Year Change | -6.32% |
| 33 Year Change | -16.84% |
| 5 Year Change | -14.21% |
| Change since IPO | -22.75% |
Recent News & Updates
Recent updates
PULSION Medical Systems (MUN:PUS) Is Investing Its Capital With Increasing Efficiency
Jan 05
Investors Shouldn't Overlook PULSION Medical Systems' (MUN:PUS) Impressive Returns On Capital
Sep 20PULSION Medical Systems (MUN:PUS) May Have Issues Allocating Its Capital
May 10Is PULSION Medical Systems (MUN:PUS) Set To Make A Turnaround?
Jan 12
Shareholder Returns
| PUS | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -0.4% | -0.4% |
| 1Y | -6.3% | -7.1% | 7.1% |
Return vs Industry: PUS matched the German Medical Equipment industry which returned -6.1% over the past year.
Return vs Market: PUS underperformed the German Market which returned 7.8% over the past year.
Price Volatility
| PUS volatility | |
|---|---|
| PUS Average Weekly Movement | 3.0% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PUS has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: PUS's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 71 | Stephan Haft | www.getinge.com/de/uber-uns/investors/pulsion-investor-relation |
PULSION Medical Systems SE engages in the development, manufacture, and distribution of monitoring, diagnosis, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include PiCCO platform, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex that offers technology in the field of perioperative medicine; PiCCO catheter used to monitor the cardiovascular system; ProAQT, a sensor used in medicine for high-risk patients and high-risk interventions; CeVOX, a technology that enables continuous monitoring of the patient's oxygen balance; LiMON, a technology used to assess and monitor liver function; and NICCI for hemodynamic monitoring. Pulsion Medical Systems SE was founded in 1990 and is based in Feldkirchen, Germany.
PULSION Medical Systems SE Fundamentals Summary
| PUS fundamental statistics | |
|---|---|
| Market cap | €134.39m |
| Earnings (TTM) | €5.03m |
| Revenue (TTM) | €35.80m |
26.7x
P/E Ratio3.8x
P/S RatioIs PUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PUS income statement (TTM) | |
|---|---|
| Revenue | €35.80m |
| Cost of Revenue | €23.39m |
| Gross Profit | €12.40m |
| Other Expenses | €7.37m |
| Earnings | €5.03m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.61 |
| Gross Margin | 34.65% |
| Net Profit Margin | 14.06% |
| Debt/Equity Ratio | 0% |
How did PUS perform over the long term?
See historical performance and comparison